Sections
Shows
Events
Big Pharma, squeezed by US govt crackdown and mounting lawsuits, eyes India's burgeoning opioid market
Johnson & Johnson and its subsidiaries ordered to pay $572 million for fuelling opioid crisis in Oklahoma
